1. Home
  2. MRVI vs ARAI Comparison

MRVI vs ARAI Comparison

Compare MRVI & ARAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • ARAI
  • Stock Information
  • Founded
  • MRVI 2014
  • ARAI 2020
  • Country
  • MRVI United States
  • ARAI United States
  • Employees
  • MRVI 560
  • ARAI N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • ARAI Diversified Commercial Services
  • Sector
  • MRVI Health Care
  • ARAI Finance
  • Exchange
  • MRVI Nasdaq
  • ARAI Nasdaq
  • Market Cap
  • MRVI 350.1M
  • ARAI 213.7M
  • IPO Year
  • MRVI 2020
  • ARAI N/A
  • Fundamental
  • Price
  • MRVI $2.42
  • ARAI $4.80
  • Analyst Decision
  • MRVI Hold
  • ARAI
  • Analyst Count
  • MRVI 10
  • ARAI 0
  • Target Price
  • MRVI $5.84
  • ARAI N/A
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • ARAI 180.4K
  • Earning Date
  • MRVI 08-11-2025
  • ARAI 08-14-2025
  • Dividend Yield
  • MRVI N/A
  • ARAI N/A
  • EPS Growth
  • MRVI N/A
  • ARAI N/A
  • EPS
  • MRVI N/A
  • ARAI N/A
  • Revenue
  • MRVI $219,830,000.00
  • ARAI $90,725.00
  • Revenue This Year
  • MRVI N/A
  • ARAI N/A
  • Revenue Next Year
  • MRVI $7.23
  • ARAI N/A
  • P/E Ratio
  • MRVI N/A
  • ARAI N/A
  • Revenue Growth
  • MRVI N/A
  • ARAI N/A
  • 52 Week Low
  • MRVI $1.67
  • ARAI $4.61
  • 52 Week High
  • MRVI $9.60
  • ARAI $40.00
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • ARAI N/A
  • Support Level
  • MRVI $2.28
  • ARAI N/A
  • Resistance Level
  • MRVI $2.47
  • ARAI N/A
  • Average True Range (ATR)
  • MRVI 0.14
  • ARAI 0.00
  • MACD
  • MRVI -0.01
  • ARAI 0.00
  • Stochastic Oscillator
  • MRVI 27.45
  • ARAI 0.00

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About ARAI Arrive AI Inc. Common Stock

Arrive AI Inc is a technology company. Its patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox-whether by drone, ground robot, or human courier. The platform provides real-time tracking, smart logistics alerts, and advanced chain-of-custody controls to support shippers, delivery services, and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots, and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting, and security systems to streamline the entire last-mile delivery experience.

Share on Social Networks: